{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T21:42:05Z","timestamp":1648676525050},"reference-count":20,"publisher":"Pharmaceutical Society of Japan","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2020,11,1]]},"DOI":"10.1248\/bpb.b20-00676","type":"journal-article","created":{"date-parts":[[2020,10,31]],"date-time":"2020-10-31T22:06:21Z","timestamp":1604181981000},"page":"1810-1813","source":"Crossref","is-referenced-by-count":0,"title":["Homocysteine Hypothesis on the Impaired Peripheral but Not Central Nervous System Oxytocin Responses in Cystathionine \u03b3-Lyase-Deficient Dam Mice"],"prefix":"10.1248","volume":"43","author":[{"given":"Noriyuki","family":"Akahoshi","sequence":"first","affiliation":[{"name":"Laboratory of Health Chemistry, Showa Pharmaceutical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waka","family":"Kamichatani","sequence":"additional","affiliation":[{"name":"Laboratory of Health Chemistry, Showa Pharmaceutical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isao","family":"Ishii","sequence":"additional","affiliation":[{"name":"Laboratory of Health Chemistry, Showa Pharmaceutical University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","unstructured":"1) Mudd SH, Levy HL, Kraus JP. Disorders of transsulfuration. <i>The Metabolic and Molecular Bases of Inherited Disease<\/i>, 8th Ed. (Scriver CR, Beaudet AL, Valle D, Sly WS eds.) McGraw-Hill, New York, pp. 2007\u20132056 (2001)."},{"key":"2","unstructured":"2) Azzini E, Ruggeri S, Polito A. Homocysteine: Its possible emerging role in at-risk population groups. <i>Int. J. Mol. Sci.<\/i>, <b>21<\/b>, 1421 (2020)."},{"key":"3","unstructured":"3) Moretti R, Caruso P. The controversial role of homocysteine in neurology: From labs to clinical practice. <i>Int. J. Mol. Sci.<\/i>, <b>20<\/b>, 231 (2019)."},{"key":"4","unstructured":"4) Zhou F, Chen S. Hyperhomocysteinemia and risk of incident cognitive outcomes: An updated dose-response meta-analysis of prospective cohort studies. <i>Ageing Res. Rev.<\/i>, <b>51<\/b>, 55\u201366 (2019)."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Imbard A, Benoist JF, Blom HJ. Neural tube defects, folic acid and methylation. <i>Int. J. Environ. Res. Public Health<\/i>, <b>10<\/b>, 4352\u20134389 (2013).","DOI":"10.3390\/ijerph10094352"},{"key":"6","unstructured":"6) Gaiday AN, Tussupkaliyev AB, Bermagambetova SK, Zhumagulova SS, Sarsembayeva LK, Dossimbetova MB, Daribay ZZ. Effect of homocysteine on pregnancy: a systematic review. <i>Chem. Biol. Interact.<\/i>, <b>293<\/b>, 70\u201376 (2018)."},{"key":"7","unstructured":"7) Watanabe M, Osada J, Aratani Y, Kluckman K, Reddick R, Malinow MR, Maeda N. Mice deficient in cystathionine beta-synthase: animal models for mild and severe homocyst(e)inemia. <i>Proc. Natl. Acad. Sci. U.S.A.<\/i>, <b>92<\/b>, 1585\u20131589 (1995)."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Ishii I, Akahoshi N, Yamada H, Nakano S, Izumi T, Suematsu M. Cystathionine \u03b3-lyase-deficient mice require dietary cysteine to protect against acute lethal myopathy and oxidative injury. <i>J. Biol. Chem.<\/i>, <b>285<\/b>, 26358\u201326368 (2010).","DOI":"10.1074\/jbc.M110.147439"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Akahoshi N, Kobayashi C, Ishizaki Y, Izumi T, Himi T, Suematsu M, Ishii I. Genetic background conversion ameliorates semi-lethality and permits behavioral analyses in cystathionine \u03b2-synthase-deficient mice, an animal model for hyperhomocysteinemia. <i>Hum. Mol. Genet.<\/i>, <b>17<\/b>, 1994\u20132005 (2008).","DOI":"10.1093\/hmg\/ddn097"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Hagiya Y, Kamata S, Mitsuoka S, Okada N, Yoshida S, Yamamoto J, Ohkubo R, Abiko Y, Yamada H, Akahoshi N, Kasahara T, Kumagai Y, Ishii I. Hemizygosity of transsulfuration genes confers increased vulnerability against acetaminophen-induced hepatotoxicity in mice. <i>Toxicol. Appl. Pharmacol.<\/i>, <b>282<\/b>, 195\u2013206 (2015).","DOI":"10.1016\/j.taap.2014.11.015"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Akiyama M, Unoki T, Shinkai Y, Ishii I, Ida T, Akaike T, Yamamoto M, Kumagai Y. Environmental electrophile-mediated toxicity in mice lacking Nrf2, CSE, or both. <i>Environ. Health Perspect.<\/i>, <b>127<\/b>, 67002 (2019).","DOI":"10.1289\/EHP4949"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Akahoshi N, Handa H, Takemoto R, Kamata S, Yoshida M, Onaka T, Ishii I. Preeclampsia-like features and partial lactation failure in mice lacking cystathionine \u03b3-lyase\u2014an animal model of cystathioninuria. <i>Int. J. Mol. Sci.<\/i>, <b>20<\/b>, 3507 (2019).","DOI":"10.3390\/ijms20143507"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Nishimori K, Young LJ, Guo Q, Wang Z, Insel TR, Matzuk MM. Oxytocin is required for nursing but is not essential for parturition or reproductive behavior. <i>Proc. Natl. Acad. Sci. U.S.A.<\/i>, <b>93<\/b>, 11699\u201311704 (1996).","DOI":"10.1073\/pnas.93.21.11699"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Takayanagi Y, Yoshida M, Bielsky IF, Ross HE, Kawamata M, Onaka T, Yanagisawa T, Kimura T, Matzuk MM, Young LJ, Nishimori K. Pervasive social deficits, but normal parturition, in oxytocin receptor-deficient mice. <i>Proc. Natl. Acad. Sci. U.S.A.<\/i>, <b>102<\/b>, 16096\u201316101 (2005).","DOI":"10.1073\/pnas.0505312102"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Akahoshi N, Minakawa T, Miyashita M, Sugiyama U, Saito C, Takemoto R, Honda A, Kamichatani W, Kamata S, Anan Y, Ishii I. Increased urinary 3-mercaptolactate excretion and enhanced passive systemic anaphylaxis in mice lacking mercaptopyruvate sulfurtransferase, a model of mercaptolactate\u2013cysteine disulfiduria. <i>Int. J. Mol. Sci.<\/i>, <b>21<\/b>, 818 (2020).","DOI":"10.3390\/ijms21030818"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Yamada H, Akahoshi N, Kamata S, Hagiya Y, Hishiki T, Nagahata Y, Matsuura T, Takano N, Mori M, Ishizaki Y, Izumi T, Kumagai Y, Kasahara T, Suematsu M, Ishii I. Methionine excess in diet induces acute lethal hepatitis in mice lacking cystathionine \u03b3-lyase, an animal model of cystathioninuria. <i>Free Radic. Biol. Med.<\/i>, <b>52<\/b>, 1716\u20131726 (2012).","DOI":"10.1016\/j.freeradbiomed.2012.02.033"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Guiraud SP, Montoliu I, Da Silva L, Dayon L, Galindo AN, Corth\u00e9sy J, Kussmann M, Martin FP. High-throughput and simultaneous quantitative analysis of homocysteine\u2013methionine cycle metabolites and co-factors in blood plasma and cerebrospinal fluid by isotope dilution LC-MS\/MS. <i>Anal. Bioanal. Chem.<\/i>, <b>409<\/b>, 295\u2013305 (2017).","DOI":"10.1007\/s00216-016-0003-1"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Oikonomidi A, Lewczuk P, Kornhuber J, Smulders Y, Linnebank M, Semmler A, Popp J. Homocysteine metabolism is associated with cerebrospinal fluid levels of soluble amyloid precursor protein and amyloid beta. <i>J. Neurochem.<\/i>, <b>139<\/b>, 324\u2013332 (2016).","DOI":"10.1111\/jnc.13766"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Valentino F, Bivona G, Butera D, Paladino P, Fazzari M, Piccoli T, Ciaccio M, La Bella V. Elevated cerebrospinal fluid and plasma homocysteine levels in ALS. <i>Eur. J. Neurol.<\/i>, <b>17<\/b>, 84\u201389 (2010).","DOI":"10.1111\/j.1468-1331.2009.02752.x"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Akahoshi N, Yokoyama A, Nagata T, Miura A, Kamata S, Ishii I. Abnormal amino acid profiles of blood and cerebrospinal fluid from cystathionine beta-synthase-deficient mice, an animal model of homocystinuria. <i>Biol. Pharm. Bull.<\/i>, <b>42<\/b>, 1054\u20131057 (2019).","DOI":"10.1248\/bpb.b19-00127"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/43\/11\/43_b20-00676\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T03:21:17Z","timestamp":1604719277000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/43\/11\/43_b20-00676\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,1]]},"references-count":20,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b20-00676","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,1]]}}}